These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21961808)

  • 1. First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland.
    Pohjankoski H; Latva K; Kautiainen H; Säilä H; Klaukka T; Virta L; Puolakka K; Pohjolainen T; Savolainen A
    Clin Exp Rheumatol; 2011; 29(5):878-81. PubMed ID: 21961808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
    Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
    Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
    Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ
    Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study.
    Salonen PH; Säilä H; Salonen JH; Linna M; Helminen M; Kauppi MJ
    Clin Exp Rheumatol; 2018; 36(3):502-507. PubMed ID: 29303705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease.
    Salonen PH; Säilä H; Salonen JH; Vuorela M; Kautiainen H; Lyytikäinen O; Kauppi MJ; Leirisalo-Repo M; Repo H
    Clin Exp Rheumatol; 2014; 32(6):979-83. PubMed ID: 25436839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating disease-modifying anti-rheumatic drugs rapidly reduces purchases of analgesic drugs in juvenile idiopathic arthritis.
    Rebane K; Aalto K; Haanpää M; Puolakka K; Virta LJ; Kautiainen H; Pohjankoski H
    Scand J Rheumatol; 2021 Jan; 50(1):28-33. PubMed ID: 32686548
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of osteoporosis drugs in patients with recent-onset rheumatoid arthritis in Finland.
    Hämäläinen H; Kautiainen H; Pohjolainen T; Virta L; Järvenpää S; Puolakka K
    Clin Exp Rheumatol; 2011; 29(5):835-8. PubMed ID: 21961794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of psychotropic medication in incident juvenile idiopathic arthritis patients from 2000 to 2014: a case-control cohort study.
    Kyllönen MS; Kautiainen H; Jääskeläinen E; Puolakka K; Vähäsalo P
    Clin Exp Rheumatol; 2023 May; 41(5):1192-1197. PubMed ID: 37083175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of juvenile idiopathic arthritis in Finland, 2000-2020.
    Uusitupa E; Rahikkala H; Sard S; Pokka T; Salo H; Kärki J; Sokka-Isler T; Backström M; Vähäsalo P
    Rheumatology (Oxford); 2024 Sep; 63(9):2355-2362. PubMed ID: 38857448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
    Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
    Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
    Anink J; Prince FH; Dijkstra M; Otten MH; Twilt M; ten Cate R; Gorter SL; Koopman-Keemink Y; van Rossum MA; Hoppenreijs EP; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2015 Nov; 54(11):1964-9. PubMed ID: 26078219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics.
    Barthel D; Ganser G; Kuester RM; Onken N; Minden K; Girschick HJ; Hospach A; Horneff G
    J Rheumatol; 2015 Nov; 42(11):2160-5. PubMed ID: 26373564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.
    Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M
    Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
    Foeldvari I; Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.